Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.
Clinical trial NCT05931484 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05931484
- Sponsor
- Forest Hills Lab
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2027-11-01
- Primary completion
- 2028-11-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.